MapLight Therapeutics Inc
MPLT
NASDAQ
Biotechnology
$11.75
USD
+0.17 (+1.47%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $519.09M
Volume 451.5K
Peer Comparison Table
(1/4) | ||||||
|---|---|---|---|---|---|---|
VSTM | Verastem Inc | $592.27M | - | +209.1% | - | |
ZURA | Zura Bio Ltd | $560.01M | - | - | - | |
ARTV | Artiva Biotherapeutics Inc | $548.55M | - | - | - | |
ASMB | Assembly Biosciences Inc | $531.10M | - | +121.1% | - | |
EIKN | Eikon Therapeutics Inc | $526.77M | - | - | - | |
MPLT | MapLight Therapeutics Inc | $519.09M | - | - | - | |
PROK | Prokidney Corp | $510.48M | - | +190.5% | - | |
TENX | Tenax Therapeutics Inc | $502.98M | - | -82.9% | - | |
KYTX | Kyverna Therapeutics Inc | $479.67M | - | - | - | |
OVID | Ovid Therapeutics Inc | $476.87M | - | +1199.6% | - |
Top Peer by Growth
Ovid Therapeutics Inc
+1199.6% YoY Revenue
Lowest P/E Ratio
Q32 Bio Inc
15.71x P/E
Best 1-Year Return
Q32 Bio Inc
+749.2% Return